Lucero Noguera-Morel

Dr. Lucero Noguera-Morel

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2020 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
ICIsabel Colmenero
Isabel Colmenero
CSC. Santonja
C. Santonja
MAM. Alonso‐Riaño
M. Alonso‐Riaño
LNLucero Noguera-Morel
Lucero Noguera-Morel
ÁHÁngela Hernández-Martín
Ángela Hernández-Martín
ATAntonio Torrelo
Antonio Torrelo
Background Chilblains ("COVID toes") are being seen with increasing frequency in children and young adults during the COVID‐19 pandemic. Detailed histopathological descriptions of COVID‐19 chilblains have not been reported, and causality of SARS‐CoV‐2 has not been established yet. Objective To describe histopathological features of Covid‐19 chilblains and explore the presence of SARS‐CoV‐2 in the tissue. Methods We examined skin biopsies from 7 paediatric patients presenting with chilblains during the COVID‐19 pandemic. Immunohistochemistry for SARS‐CoV‐2 was performed in all cases and electron microscopy in one. Results Histopathology showed variable degrees of lymphocytic vasculitis ranging from endothelial swelling and endothelialitis to fibrinoid necrosis and thrombosis. Purpura, superficial and deep perivascular lymphocytic inflammation with perieccrine accentuation, oedema, and mild vacuolar interface damage were also seen. SARS‐CoV‐2 immunohistochemistry was positive in endothelial cells and epithelial cells of eccrine glands. Coronavirus particles were found in the cytoplasm of endothelial cells on electron microscopy. Conclusions Although the clinical and histopathological features were similar to other forms of chilblains, the presence of viral particles in the endothelium and the histological evidence of vascular damage, support a causal relation of the lesions with SARS‐CoV‐2. Endothelial damage induced by the virus could be the key mechanism in the pathogenesis of COVID‐19 chilblains and perhaps also in a group of patients severely affected by COVID‐19 presenting with features of microangiopathic damage.

22 May 2020 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
DADavid Andina
David Andina
LNLucero Noguera-Morel
Lucero Noguera-Morel
MBMarta Bascuas‐Arribas
Marta Bascuas‐Arribas
JGJara Gaitero‐Tristán
Jara Gaitero‐Tristán
JAJosé Antonio Alonso‐Cadenas
José Antonio Alonso‐Cadenas
ATAntonio Torrelo
Antonio Torrelo

23 May 2020 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
ATAntonio Torrelo
Antonio Torrelo
DADavid Andina
David Andina
CSCarlos Santonja
Carlos Santonja
LNLucero Noguera-Morel
Lucero Noguera-Morel
MBMarta Bascuas‐Arribas
Marta Bascuas‐Arribas
ICIsabel Colmenero
Isabel Colmenero

12 August 2016 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
ATAntonio Torrelo
Antonio Torrelo
LNLucero Noguera-Morel
Lucero Noguera-Morel
ÁHÁngela Hernández-Martín
Ángela Hernández-Martín
DCD. Clemente
D. Clemente
JBJ.M. Barja
J.M. Barja
LRL. Requena
L. Requena

20 November 2020 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
LNLucero Noguera-Morel
Lucero Noguera-Morel
ÁHÁngela Hernández-Martín
Ángela Hernández-Martín
ATAntonio Torrelo
Antonio Torrelo

27 July 2015 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
MPMaría Lía Pieretti
María Lía Pieretti
RARebeca Alcalá
Rebeca Alcalá
PBPaula Boggio
Paula Boggio
LNLucero Noguera-Morel
Lucero Noguera-Morel
MPMaría Librada Porriño-Bustamante
María Librada Porriño-Bustamante
ATAntonio Torrelo
Antonio Torrelo